scholarly article | Q13442814 |
P356 | DOI | 10.3851/IMP2724 |
P698 | PubMed publication ID | 24429380 |
P50 | author | Marek Smieja | Q87794625 |
Ann N Burchell | Q91076503 | ||
P2093 | author name string | Curtis Cooper | |
Janet M Raboud | |||
Sean B Rourke | |||
Jennifer Gillis | |||
Angela Cescon | |||
OHTN Cohort Study Group | |||
P433 | issue | 3 | |
P921 | main subject | cardiovascular disease | Q389735 |
anti-retroviral agent | Q50430310 | ||
P304 | page(s) | 309-317 | |
P577 | publication date | 2014-01-16 | |
P1433 | published in | Antiviral Therapy | Q4775353 |
P1476 | title | Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals | |
P478 | volume | 19 |
Q36401521 | A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study |
Q47405719 | A systematic review of the associations between HIV/HCV coinfection and biomarkers of cardiovascular disease. |
Q43163566 | Atherosclerosis is associated with a higher risk of hepatic steatosis in HIV-infected patients |
Q60303063 | Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017) |
Q38352065 | Coronary artery disease in patients with HIV infection |
Q39008634 | Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection. |
Q38679137 | FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients |
Q41033591 | Fibroblast growth factor 23: associations with antiretroviral therapy in patients co-infected with HIV and hepatitis C. |
Q92385797 | Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study |
Q47593919 | HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome |
Q36368959 | HIV infection as vascular risk: A systematic review of the literature and meta-analysis |
Q34617496 | HIV protease inhibitors in gut barrier dysfunction and liver injury |
Q38787354 | HIV/HCV coinfection and the risk of cardiovascular disease: A meta-analysis. |
Q35775807 | Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade |
Q41708794 | Hepatitis B virus infection and decreased risk of stroke: a meta-analysis |
Q40989818 | Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients |
Q35158116 | Hepatitis C virus seroconversion among HIV-positive men who have sex with men with no history of injection drug use: Results from a clinical HIV cohort |
Q26851535 | Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus |
Q38946641 | Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients |
Q35952565 | Micronutrient Deficiencies and Plasmodium vivax Malaria among Children in the Brazilian Amazon |
Q38832560 | Neurologic Complications in Treated HIV-1 Infection |
Q34803775 | PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study |
Q47169604 | Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review. |
Q38261508 | Risk of coronary heart disease in patients with HIV infection |
Q33803319 | Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era. |
Q36754790 | Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis. |
Search more.